Diagnostic performance of perilesional radiomics analysis of contrast-enhanced mammography for the differentiation of benign and malignant breast lesions
- PMID: 34189600
- DOI: 10.1007/s00330-021-08134-y
Diagnostic performance of perilesional radiomics analysis of contrast-enhanced mammography for the differentiation of benign and malignant breast lesions
Abstract
Objective: To conduct perilesional region radiomics analysis of contrast-enhanced mammography (CEM) images to differentiate benign and malignant breast lesions.
Methods and materials: This retrospective study included patients who underwent CEM from November 2017 to February 2020. Lesion contours were manually delineated. Perilesional regions were automatically obtained. Seven regions of interest (ROIs) were obtained for each lesion, including the lesion ROI, annular perilesional ROIs (1 mm, 3 mm, 5 mm), and lesion + perilesional ROIs (1 mm, 3 mm, 5 mm). Overall, 4,098 radiomics features were extracted from each ROI. Datasets were divided into training and testing sets (1:1). Seven classification models using features from the seven ROIs were constructed using LASSO regression. Model performance was assessed by the AUC with 95% CI.
Results: Overall, 190 women with 223 breast lesions (101 benign; 122 malignant) were enrolled. In the testing set, the annular perilesional ROI of 3-mm model showed the highest AUC of 0.930 (95% CI: 0.882-0.977), followed by the annular perilesional ROI of 1 mm model (AUC = 0.929; 95% CI: 0.881-0.978) and the lesion ROI model (AUC = 0.909; 95% CI: 0.857-0.961). A new model was generated by combining the predicted probabilities of the lesion ROI and annular perilesional ROI of 3-mm models, which achieved a higher AUC in the testing set (AUC = 0.940).
Conclusions: Annular perilesional radiomics analysis of CEM images is useful for diagnosing breast cancers. Adding annular perilesional information to the radiomics model built on the lesion information may improve the diagnostic performance.
Key points: • Radiomics analysis of the annular perilesional region of 3 mm in CEM images may provide valuable information for the differential diagnosis of benign and malignant breast lesions. • The radiomics information from the lesion region and the annular perilesional region may be complementary. Combining the predicted probabilities of the models constructed by the features from the two regions may improve the diagnostic performance of radiomics models.
Keywords: Breast cancer; Machine learning; Mammography.
© 2021. European Society of Radiology.
Similar articles
-
Intra- and peritumoral radiomics for predicting malignant BiRADS category 4 breast lesions on contrast-enhanced spectral mammography: a multicenter study.Eur Radiol. 2023 Aug;33(8):5411-5422. doi: 10.1007/s00330-023-09513-3. Epub 2023 Apr 4. Eur Radiol. 2023. PMID: 37014410
-
Intratumoral and peritumoral radiomics for preoperatively predicting the axillary non-sentinel lymph node metastasis in breast cancer on the basis of contrast-enhanced mammography: a multicenter study.Br J Radiol. 2023 Mar;96(1143):20220068. doi: 10.1259/bjr.20220068. Epub 2023 Jan 12. Br J Radiol. 2023. PMID: 36542866 Free PMC article.
-
Combining Deep Learning and Handcrafted Radiomics for Classification of Suspicious Lesions on Contrast-enhanced Mammograms.Radiology. 2023 Jun;307(5):e221843. doi: 10.1148/radiol.221843. Radiology. 2023. PMID: 37338353
-
Radiomics to Differentiate Malignant and Benign Breast Lesions: A Systematic Review and Diagnostic Test Accuracy Meta-Analysis.Cureus. 2023 Nov 18;15(11):e49015. doi: 10.7759/cureus.49015. eCollection 2023 Nov. Cureus. 2023. PMID: 38024014 Free PMC article. Review.
-
Radiomics in breast cancer classification and prediction.Semin Cancer Biol. 2021 Jul;72:238-250. doi: 10.1016/j.semcancer.2020.04.002. Epub 2020 May 1. Semin Cancer Biol. 2021. PMID: 32371013 Review.
Cited by
-
Attention-based deep learning for breast lesions classification on contrast enhanced spectral mammography: a multicentre study.Br J Cancer. 2023 Mar;128(5):793-804. doi: 10.1038/s41416-022-02092-y. Epub 2022 Dec 15. Br J Cancer. 2023. PMID: 36522478 Free PMC article.
-
A Lightweight Breast Cancer Mass Classification Model Utilizing Simplified Swarm Optimization and Knowledge Distillation.Bioengineering (Basel). 2025 Jun 11;12(6):640. doi: 10.3390/bioengineering12060640. Bioengineering (Basel). 2025. PMID: 40564456 Free PMC article.
-
Empowering breast cancer diagnosis and radiology practice: advances in artificial intelligence for contrast-enhanced mammography.Front Radiol. 2024 Jan 5;3:1326831. doi: 10.3389/fradi.2023.1326831. eCollection 2023. Front Radiol. 2024. PMID: 38249158 Free PMC article. Review.
-
Predicting Human Epidermal Growth Factor Receptor 2 Expression in Breast Cancer Based on Radiomics of MRI Habitat and US.Breast Cancer (Dove Med Press). 2025 Aug 15;17:711-725. doi: 10.2147/BCTT.S535697. eCollection 2025. Breast Cancer (Dove Med Press). 2025. PMID: 40836946 Free PMC article.
-
MRI radiomics for diagnosing small BI-RADS 4 breast lesions: an interpretable model.Quant Imaging Med Surg. 2025 Jun 6;15(6):5060-5072. doi: 10.21037/qims-24-1893. Epub 2025 May 23. Quant Imaging Med Surg. 2025. PMID: 40606393 Free PMC article.
References
-
- Lewin JM, Isaacs PK, Vance V, Larke FJ (2003) Dual-energy contrast-enhanced digital subtraction mammography: feasibility. Radiology 229:261–268 - PubMed
-
- Jochelson MS, Lobbes MBI (2021) Contrast-enhanced mammography: state of the Art. Radiology 299:36–48 - PubMed
-
- Sogani J, Mango VL, Keating D, Sung JS, Jochelson MS (2021) Contrast-enhanced mammography: past, present, and future. Clin Imaging 69:269–279 - PubMed
-
- Ghaderi KF, Phillips J, Perry H, Lotfi P, Mehta TS (2019) Contrast-enhanced mammography: current applications and future directions. Radiographics 39:1907–1920 - PubMed
-
- Perry H, Phillips J, Dialani V et al (2018) Contrast-enhanced mammography: a systematic guide to interpretation and reporting. AJR Am J Roentgenol 212:222–231
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical